ArticleJournal of the American College of Emergency Physicians open2025
Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues.
Article in Journal of the American College of Emergency Physicians open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preventing Cardiovascular-Kidney-Metabolic Syndrome Progression: Pharmacologic Approaches and Pharmacists' Contributions.Cardiorenal medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe the implementation and impact of a collaborative practice agreement (CPA) for emergency medicine pharmacists (EMPs) that grants them broad prescriptive authority to resolve outpatient discharge prescription issues independently. Methods: We conducted a retrospective chart review of all prescriptions written by EMPs under a CPA to resolve discharge prescription issues at a 70-bed emergency department (ED) within a large health system in South Dallas, Texas. This review covered the period from November 1, 2021, to June 30, 2023. EMPs were authorized to independently address prescription problems without a provider's direct involvement. We collected data on patient demographics, the types of issues encountered, pharmacist interventions, and the rates of patient revisits at 3 and 6 months related to the original prescription issue. Results: EMPs resolved 295 discharge prescription issues by sending a total of 340 prescriptions, representing 11.6% of the 2919 prescriptions issued by EMPs during the study period. The most common issues addressed were related to insurance or affordability (28.1%) and medication unavailability (22%). EMPs most frequently responded by prescribing therapeutic alternatives (59.7%). Among the 295 patients with resolved prescription issues, 11.2% returned to the ED within 3 months, primarily due to persistent symptoms. At the 6-month mark, 13.2% of the 295 patients had returned to the ED, with all additional revisits citing an inability to follow-up with their provider. Analgesics were the most prescribed medication class (37.3%). No major safety concerns were identified, and all prescriptive actions were retrospectively met with provider agreement. Conclusion: Broad EMP prescriptive authority through CPAs enables independent resolution of postdischarge prescription issues, improving care continuity, potentially reducing ED revisits, and sparing provider time to optimally take care of patients. This model can serve as a framework for other institutions aiming to optimize pharmacist-driven transitions of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.